USAID, PEPFAR Brief Addresses Hormonal Contraception Use, HIV Risk

“While evidence of a tie between some injectable hormonal contraceptives and an increased risk of HIV acquisition remains incomplete, that potential risk must be balanced against the life-saving benefits of preventing unintended pregnancy, a brief [.pdf] from USAID’s Office of Population and Reproductive Health says,” the Center for Global Health Policy’s “Science Speaks” blog reports. The brief, prepared in collaboration with PEPFAR, “concludes that the search for conclusive evidence of acquisition risk, as well as for safe, affordable technologies to prevent both unintended pregnancy and HIV acquisition, continues,” the blog notes (Barton, 9/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.